Company intelligence / Profile preview

New Myrex Laboratories

Sta. Maria, Bulacan, Philippinesdnb.com ↗

Ownership: Private
Development stage: Other

Overview

New Myrex Laboratories is a Philippine-based pharmaceutical manufacturer with commercial operations focused on producing generic drugs and antibiotics. The company has a history as both a trader/distributor and manufacturer, with expanded toll manufacturing services since 2002. It was acquired by the Kylemed Group in 2006 to broaden its market reach. No clinical trial results are reported as it primarily manufactures established products rather than developing new molecular entities.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeAntibiotics (specifically penicillins and derivatives)Pharmaceutical preparations
Industry: Biotech

Beyond the preview

Go deeper on New Myrex Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Myrex Laboratories.

Explore the full profile